show episodes
 
N
NEI Podcast

51
NEI Podcast

Neuroscience Education Institute

Unsubscribe
Unsubscribe
Monthly+
 
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
 
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
 
P
Psychcast

1
Psychcast

Medscape Professional Network

Unsubscribe
Unsubscribe
Monthly
 
Official podcast feed of MDedge Psychiatry, part of the Medscape Professional Network. Episodes include interviews with leaders in psychiatry and psychology, masterclass lectures, and clinical perspective. Interviews are hosted by Dr. Lorenzo Norris, MD, Clinical Correlaction featuers Dr. Renee Kohanski, MD, and lecturers are chosen by MDedge Psychiatry. The information in this podcast is provided for informational and educational purposes only.
 
Loading …
show series
 
When a patient presents with markedly elevated temperature and altered mental status, is it neuroleptic malignant syndrome or serotonin syndrome? If you do not have a medication list, some clinical signs may help. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium Memberships here Earn 0.5 CMEs: Quick …
 
This episode discusses how to improve psychotropic drug adherence by targeting the reasons for nonadherence. It also discusses a 3-tiered approach to enhancing adherence, a patient questionnaire to evaluate the reasons for not taking medications, the top reasons for poor antipsychotic adherence, and the positive aspects of taking medications. Final…
 
How risky is esketamine? In this episode, we examine the safety of esketamine using postmarketing data that have been reported since the drug was approved and released. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium Memberships here Earn 0.5 CMEs: Quick Take Vol. 27 Postmarketing Safety Concerns Wi…
 
What is unique about collaborative care, when it comes to mental health? Can you share some of the step-by -step guide to implementing the core model in clinical practice for collaborative care? In this episode, Dr. Anna Ratzliff answers these questions and much more! Dr. Anna Ratzliff is a national expert on collaborative care and specifically, on…
 
This episode discusses an algorithm for assessing adherence; the reasons for suboptimal adherence, including adverse drug reactions; measuring perceived side effects with the FIBSER scale; and how to help individuals communicate with providers about side effects. Faculty: Martha Sajatovic, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn m…
 
Delirium has been frequently found in patients who test positive for COVID-19. It has additional features that we do not typically see in ordinary delirium. The critical question is: How do you manage these patients? Guest: Scott Beach, M.D. Interviewer: Wegdan Rashad, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium Mem…
 
This episode discusses the assessment of adherence: Self-report, electronic medication monitoring systems, rating scales, medication possession ratio, questions for assessing medication adherence, and the recommended frequency of adherence monitoring. Faculty: Martha Sajatovic, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Pr…
 
In this episode, Dr. Andrew Cutler interviews Dr. Jonathan Meyer on best practices and strategies for improving clinician and patient communication, medication adherence, and collaboration in the community when it comes to treating schizophrenia. Optional CE Credits / Certificate Instructions: After listening to the podcast, to take the optional po…
 
A new randomized trial suggests that the efficacy of antidepressants for the treatment of bipolar depression is no greater than placebo. This tips the meta-analytic balance scale, which already pointed in this direction. Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium Memberships here Earn 0.5 CMEs:…
 
This podcast offers a discussion on catatonia and delirium as well as treatments for their co-occurrence. Treatments discussed include benzodiazepines, amantadine, and memantine. We also address the management of COVID-19 delirium with antipsychotics. Faculty: Scott Beach, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D. Learn more about Premium…
 
Is psilocybin a potential treatment for major depression? There's certainly been a lot of press coverage, but to date, the reports are largely open trials in a variety of conditions, including OCD, substance use, PTSD, and patients with cancer and psychological distress. Against that backdrop, a randomized trial of psilocybin for major depression i…
 
This podcast features a discussion on the need to highlight anhedonia and anergia as core symptoms of depression. We also cover the clinical utility of MAOIs in treating patients with melancholic or biological depression and Parkinson's disease. Guest: Ken Gillman, M.D.; Interviewer: Wegdan Rashad, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login